BRAF and neoplasm: The fact that DpR nearly directly precedes disease progression and, therefore, treatment failure, especially in patients with BRAF-MT mCRC, is alarming and could stimulate alertness in the clinical management—particularly regarding the frequency of radiological control of tumor dynamics—of these patients.